Stay updated on Primary Oral Insulin Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.

Latest updates to the Primary Oral Insulin Immunotherapy Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe clinical-trial record for the GPPAD-POInT study is displayed, describing a completed phase 2 trial of oral insulin for type 1 diabetes prevention in genetically at-risk infants. The record includes study design, eligibility criteria, outcomes, participating locations, and publication details.SummaryDifference48%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.3%

- Check25 days agoChange DetectedAn NIH banner announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the study page’s 403 Forbidden error.SummaryDifference1%

- Check32 days agoChange DetectedThe footer’s site revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe revision label in the footer of the ClinicalTrials.gov 403 Forbidden page changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a 403 Forbidden error page with a minimal header and navigation, replacing the previous study record content. The additions show the 403 text, a basic header, a Home link, and a revision notice.SummaryDifference18%

Stay in the know with updates to Primary Oral Insulin Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Primary Oral Insulin Immunotherapy Clinical Trial page.